ロード中...
Assessment of tumor oxygenation and its impact on treatment response in bevacizumab-treated recurrent glioblastoma
Antiantiogenic therapy with bevacizumab in recurrent glioblastoma is currently understood to both reduce microvascular density and to prune abnormal tumor microvessels. Microvascular pruning and the resulting vascular normalization are hypothesized to reduce tumor hypoxia and increase supply of syst...
保存先:
| 出版年: | J Cereb Blood Flow Metab |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5381446/ https://ncbi.nlm.nih.gov/pubmed/26861817 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0271678X16630322 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|